 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Previous Article | Next Article
The Journal of Neuroscience, September 15, 2002, 22(18):7873-7878
Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-
In Vivo by Immunotherapy
Brian J. Bacskai1, Stephen T. Kajdasz1, Megan E. McLellan1, Dora Games2, Peter Seubert2, Dale Schenk2, and Bradley T. Hyman1 1 Alzheimer's Disease Research Laboratory, Massachusetts General Hospital, Charlestown, Massachusetts 02129, and 2 Elan Pharmaceuticals, South San Francisco, California 94080
Transgenic (Tg) mouse models overexpressing amyloid precursor protein (APP) develop senile plaques similar to those found in Alzheimer's disease in an age-dependent manner. Recent reports demonstrated that immunotherapy is effective at preventing or removing amyloid-
deposits in the mouse models. To characterize the mechanisms involved in clearance, we used antibodies of either IgG1 (10d5) or IgG2b (3d6) applied directly to the brains of 18-month-old Tg2576 or 20-month-old PDAPP mice. Both 10d5 and 3d6 led to clearance of 50% of diffuse amyloid deposits in both animal models within 3 d. Fc receptor-mediated clearance has been shown to be important in an ex vivo assay showing antibody-mediated clearance of plaques by microglia. We now show, using in vivo multiphoton microscopy, that FITC-labeled F(ab')2 fragments of 3d6 (which lack the Fc region of the antibody) also led to clearance of 45% of the deposits within 3 d, similar to the results obtained with full-length 3d6 antibody. This result suggests that direct disruption of plaques, in addition to Fc-dependent phagocytosis, is involved in the antibody-mediated clearance of amyloid-
Key words: amyloid; transgenic; Alzheimer; multiphoton; imaging; senile plaque; microglia; immunotherapy; antibody
Copyright © 2002 Society for Neuroscience 0270-6474/02/22187873-06$05.00/0
This article has been cited by other articles:
K. Yamada, C. Yabuki, P. Seubert, D. Schenk, Y. Hori, S. Ohtsuki, T. Terasaki, T. Hashimoto, and T. Iwatsubo
A{beta} Immunotherapy: Intracerebral Sequestration of A{beta} by an Anti-A{beta} Monoclonal Antibody 266 with High Affinity to Soluble A{beta}
J. Neurosci., September 9, 2009; 29(36): 11393 - 11398.
[Abstract] [Full Text] [PDF]
V. Zota, A. Nemirovsky, R. Baron, Y. Fisher, D. J. Selkoe, D. M. Altmann, H. L. Weiner, and A. Monsonego
HLA-DR Alleles in Amyloid {beta}-Peptide Autoimmunity: A Highly Immunogenic Role for the DRB1*1501 Allele
J. Immunol., September 1, 2009; 183(5): 3522 - 3530.
[Abstract] [Full Text] [PDF]
K. L. Lanctot, R. D. Rajaram, and N. Herrmann
Review: Therapy for Alzheimer's disease: how effective are current treatments?
Therapeutic Advances in Neurological Disorders, May 1, 2009; 2(3): 163 - 180.
[Abstract] [PDF]
D. R. Thakker, M. R. Weatherspoon, J. Harrison, T. E. Keene, D. S. Lane, W. F. Kaemmerer, G. R. Stewart, and L. L. Shafer
Intracerebroventricular amyloid-{beta} antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice
PNAS, March 17, 2009; 106(11): 4501 - 4506.
[Abstract] [Full Text] [PDF]
J. Koenigsknecht-Talboo, M. Meyer-Luehmann, M. Parsadanian, M. Garcia-Alloza, M. B. Finn, B. T. Hyman, B. J. Bacskai, and D. M. Holtzman
Rapid Microglial Response Around Amyloid Pathology after Systemic Anti-A{beta} Antibody Administration in PDAPP Mice
J. Neurosci., December 24, 2008; 28(52): 14156 - 14164.
[Abstract] [Full Text] [PDF]
T. Yoshihara, S. Takiguchi, A. Kyuno, K. Tanaka, S. Kuba, S. Hashiguchi, Y. Ito, T. Hashimoto, T. Iwatsubo, S. Tsuyama, et al.
Immunoreactivity of Phage Library-derived Human Single-Chain Antibodies to Amyloid Beta Conformers In Vitro
J. Biochem., April 1, 2008; 143(4): 475 - 486.
[Abstract] [Full Text] [PDF]
V. Vasilevko, F. Xu, M. L. Previti, W. E. Van Nostrand, and D. H. Cribbs
Experimental Investigation of Antibody-Mediated Clearance Mechanisms of Amyloid- in CNS of Tg-SwDI Transgenic Mice
J. Neurosci., December 5, 2007; 27(49): 13376 - 13383.
[Abstract] [Full Text] [PDF]
T. L. Spires-Jones, M. Meyer-Luehmann, J. D. Osetek, P. B. Jones, E. A. Stern, B. J. Bacskai, and B. T. Hyman
Impaired Spine Stability Underlies Plaque-Related Spine Loss in an Alzheimer's Disease Mouse Model
Am. J. Pathol., October 1, 2007; 171(4): 1304 - 1311.
[Abstract] [Full Text] [PDF]
D. Tampellini, J. Magrane, R. H. Takahashi, F. Li, M. T. Lin, C. G. Almeida, and G. K. Gouras
Internalized Antibodies to the Abeta Domain of APP Reduce Neuronal Abeta and Protect against Synaptic Alterations
J. Biol. Chem., June 29, 2007; 282(26): 18895 - 18906.
[Abstract] [Full Text] [PDF]
C. R. Jack Jr, M. Marjanska, T. M. Wengenack, D. A. Reyes, G. L. Curran, J. Lin, G. M. Preboske, J. F. Poduslo, and M. Garwood
Magnetic Resonance Imaging of Alzheimer's Pathology in the Brains of Living Transgenic Mice: A New Tool in Alzheimer's Disease Research
Neuroscientist, February 1, 2007; 13(1): 38 - 48.
[Abstract] [PDF]
Y. Levites, L. A. Smithson, R. W. Price, R. S. Dakin, B. Yuan, M. R. Sierks, J. Kim, E. McGowan, D. K. Reed, T. L. Rosenberry, et al.
Insights into the mechanisms of action of anti-A{beta} antibodies in Alzheimer's disease mouse models
FASEB J, December 1, 2006; 20(14): 2576 - 2578.
[Abstract] [Full Text] [PDF]
Y. Levites, K. Jansen, L. A. Smithson, R. Dakin, V. M. Holloway, P. Das, and T. E. Golde
Intracranial Adeno-Associated Virus-Mediated Delivery of Anti-Pan Amyloid beta, Amyloid beta40, and Amyloid beta42 Single-Chain Variable Fragments Attenuates Plaque Pathology in Amyloid Precursor Protein Mice.
J. Neurosci., November 15, 2006; 26(46): 11923 - 11928.
[Abstract] [Full Text] [PDF]
H.-W. Klafki, M. Staufenbiel, J. Kornhuber, and J. Wiltfang
Therapeutic approaches to Alzheimer's disease
Brain, November 1, 2006; 129(11): 2840 - 2855.
[Abstract] [Full Text] [PDF]
D. M. Wilcock, J. Alamed, P. E. Gottschall, J. Grimm, A. Rosenthal, J. Pons, V. Ronan, K. Symmonds, M. N. Gordon, and D. Morgan
Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice.
J. Neurosci., May 17, 2006; 26(20): 5340 - 5346.
[Abstract] [Full Text] [PDF]
A. M. Floden and C. K. Combs
Beta-amyloid stimulates murine postnatal and adult microglia cultures in a unique manner.
J. Neurosci., April 26, 2006; 26(17): 4644 - 4648.
[Abstract] [Full Text] [PDF]
E. B. Lee, L. Z. Leng, B. Zhang, L. Kwong, J. Q. Trojanowski, T. Abel, and V. M.-Y. Lee
Targeting Amyloid-beta Peptide (Abeta) Oligomers by Passive Immunization with a Conformation-selective Monoclonal Antibody Improves Learning and Memory in Abeta Precursor Protein (APP) Transgenic Mice
J. Biol. Chem., February 17, 2006; 281(7): 4292 - 4299.
[Abstract] [Full Text] [PDF]
X. Yue, M. Lu, T. Lancaster, P. Cao, S.-I. Honda, M. Staufenbiel, N. Harada, Z. Zhong, Y. Shen, and R. Li
Brain estrogen deficiency accelerates A{beta} plaque formation in an Alzheimer's disease animal model
PNAS, December 27, 2005; 102(52): 19198 - 19203.
[Abstract] [Full Text] [PDF]
J. Koenigsknecht-Talboo and G. E. Landreth
Microglial Phagocytosis Induced by Fibrillar {beta}-Amyloid and IgGs Are Differentially Regulated by Proinflammatory Cytokines
J. Neurosci., September 7, 2005; 25(36): 8240 - 8249.
[Abstract] [Full Text] [PDF]
S. Rebe and B. Solomon
Deglycosylation of anti-{beta} amyloid antibodies inhibits microglia activation in BV-2 cellular model
American Journal of Alzheimer's Disease and Other Dementias, September 1, 2005; 20(5): 303 - 313.
[Abstract] [PDF]
T. L. Spires, M. Meyer-Luehmann, E. A. Stern, P. J. McLean, J. Skoch, P. T. Nguyen, B. J. Bacskai, and B. T. Hyman
Dendritic Spine Abnormalities in Amyloid Precursor Protein Transgenic Mice Demonstrated by Gene Transfer and Intravital Multiphoton Microscopy
J. Neurosci., August 3, 2005; 25(31): 7278 - 7287.
[Abstract] [Full Text] [PDF]
R. E. Hartman, Y. Izumi, K. R. Bales, S. M. Paul, D. F. Wozniak, and D. M. Holtzman
Treatment with an Amyloid-{beta} Antibody Ameliorates Plaque Load, Learning Deficits, and Hippocampal Long-Term Potentiation in a Mouse Model of Alzheimer's Disease
J. Neurosci., June 29, 2005; 25(26): 6213 - 6220.
[Abstract] [Full Text] [PDF]
F.-S. Shie, R. M. Breyer, and T. J. Montine
Microglia Lacking E Prostanoid Receptor Subtype 2 Have Enhanced A{beta} Phagocytosis yet Lack A{beta}-Activated Neurotoxicity
Am. J. Pathol., April 1, 2005; 166(4): 1163 - 1172.
[Abstract] [Full Text] [PDF]
D. A. Bennett and D. M. Holtzman
Immunization therapy for Alzheimer disease?
Neurology, January 11, 2005; 64(1): 10 - 12.
[Full Text] [PDF]
D. S. Gelinas, K. DaSilva, D. Fenili, P. St. George-Hyslop, and J. McLaurin
Immunotherapy for Alzheimer's disease
PNAS, October 5, 2004; 101(suppl_2): 14657 - 14662.
[Abstract] [Full Text] [PDF]
T. Bussiere, F. Bard, R. Barbour, H. Grajeda, T. Guido, K. Khan, D. Schenk, D. Games, P. Seubert, and M. Buttini
Morphological Characterization of Thioflavin-S-Positive Amyloid Plaques in Transgenic Alzheimer Mice and Effect of Passive A{beta} Immunotherapy on Their Clearance
Am. J. Pathol., September 1, 2004; 165(3): 987 - 995.
[Abstract] [Full Text] [PDF]
E. M. Sigurdsson, E. Knudsen, A. Asuni, C. Fitzer-Attas, D. Sage, D. Quartermain, F. Goni, B. Frangione, and T. Wisniewski
An Attenuated Immune Response Is Sufficient to Enhance Cognition in an Alzheimer's Disease Mouse Model Immunized with Amyloid-{beta} Derivatives
J. Neurosci., July 14, 2004; 24(28): 6277 - 6282.
[Abstract] [Full Text] [PDF]
L. Bergamaschini, E. Rossi, C. Storini, S. Pizzimenti, M. Distaso, C. Perego, A. De Luigi, C. Vergani, and M. Grazia De Simoni
Peripheral Treatment with Enoxaparin, a Low Molecular Weight Heparin, Reduces Plaques and {beta}-Amyloid Accumulation in a Mouse Model of Alzheimer's Disease
J. Neurosci., April 28, 2004; 24(17): 4181 - 4186.
[Abstract] [Full Text] [PDF]
J. A. Lombardo, E. A. Stern, M. E. McLellan, S. T. Kajdasz, G. A. Hickey, B. J. Bacskai, and B. T. Hyman
Amyloid-{beta} Antibody Treatment Leads to Rapid Normalization of Plaque-Induced Neuritic Alterations
J. Neurosci., November 26, 2003; 23(34): 10879 - 10883.
[Abstract] [Full Text] [PDF]
P. Das, V. Howard, N. Loosbrock, D. Dickson, M. P. Murphy, and T. E. Golde
Amyloid-{beta} Immunization Effectively Reduces Amyloid Deposition in FcR{gamma}-/- Knock-Out Mice
J. Neurosci., September 17, 2003; 23(24): 8532 - 8538.
[Abstract] [Full Text] [PDF]
D. L. Sparks and B. G. Schreurs
Trace amounts of copper in water induce {beta}-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease
PNAS, September 16, 2003; 100(19): 11065 - 11069.
[Abstract] [Full Text] [PDF]
D. M. Wilcock, G. DiCarlo, D. Henderson, J. Jackson, K. Clarke, K. E. Ugen, M. N. Gordon, and D. Morgan
Intracranially Administered Anti-Abeta Antibodies Reduce beta -Amyloid Deposition by Mechanisms Both Independent of and Associated with Microglial Activation
J. Neurosci., May 1, 2003; 23(9): 3745 - 3751.
[Abstract] [Full Text] [PDF]
M. E. McLellan, S. T. Kajdasz, B. T. Hyman, and B. J. Bacskai
In Vivo Imaging of Reactive Oxygen Species Specifically Associated with Thioflavine S-Positive Amyloid Plaques by Multiphoton Microscopy
J. Neurosci., March 15, 2003; 23(6): 2212 - 2217.
[Abstract] [Full Text] [PDF]
F. Bard, R. Barbour, C. Cannon, R. Carretto, M. Fox, D. Games, T. Guido, K. Hoenow, K. Hu, K. Johnson-Wood, et al.
Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology
PNAS, February 18, 2003; 100(4): 2023 - 2028.
[Abstract] [Full Text] [PDF]
Y. Matsuoka, M. Saito, J. LaFrancois, M. Saito, K. Gaynor, V. Olm, L. Wang, E. Casey, Y. Lu, C. Shiratori, et al.
Novel Therapeutic Approach for the Treatment of Alzheimer's Disease by Peripheral Administration of Agents with an Affinity to beta -Amyloid
J. Neurosci., January 1, 2003; 23(1): 29 - 33.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|